Table 2.

Univariate and multivariate logistic regression analyses of logarithmization transformed plasma medians of IL6, IFN-γ, IL10, IL17A, and CRP levels as independent risk factors of human aneurismal disease.

Dependent variables	AAA status	Percentiles 25 – 50 – 75	OR	Adjusted OR^*
Ln [IL6]	Non-AAA	0.00 1.52 4.92	0.88 (0.78; 1.04) P=0.141	0.91 (0.76; 1.08) P=0.272
Ln [IL6]	AAA	0.00 1.37 3.93	0.88 (0.78; 1.04) P=0.141	0.91 (0.76; 1.08) P=0.272
Ln [IFN-γ]	Non-AAA	5.79 21.24 87.23	0.91 (0.82; 0.99) P=0.044	0.98 (0.87; 1.10) P=0.743
Ln [IFN-γ]	AAA	6.54 16.07 40.46	0.91 (0.82; 0.99) P=0.044	0.98 (0.87; 1.10) P=0.743
Ln [IL10]	Non-AAA	0.00 13.46 113.1	0.91 (0.85; 0.98) P=0.011	0.96 (0.88; 1.05) P=0.372
Ln [IL10]	AAA	0.00 9.74 55.47	0.91 (0.85; 0.98) P=0.011	0.96 (0.88; 1.05) P=0.372
Ln [IL17A]	Non-AAA	0.00 0.00 26.99	0.98 (0.90; 1.06) P=0.585	1.012 (0.92; 1.12) P=0.735
Ln [IL17A]	AAA	0.00 0.00 9.75	0.98 (0.90; 1.06) P=0.585	1.012 (0.92; 1.12) P=0.735
Ln [CRP]	Non-AAA	0.80 1.70 3.95	1.54 (1.31; 1.82) P<0.001	1.41 (1.17; 1.70) P<0.001
Ln [CRP]	AAA	1.58 3.00 6.30	1.54 (1.31; 1.82) P<0.001	1.41 (1.17; 1.70) P<0.001

Adjusted for smoking, diabetes, hypertension, use of β-blocker, statins, NSAIDs, systolic blood pressure, diastolic blood pressure, age, and body mass index.